According to the latest report by UNAIDS, a U.N. agency exclusively responsible for AIDS, the number of new HIV infections worldwide totaled about 1.5 million in 2021, more than a million more than the global target.UNAIDS, which declared to terminate AIDS by 2030, puts its foremost priority on HIV
A government report showed that eight out of 10 deaths in Korea last year were due to chronic diseases.The Korea Disease Control and Prevention Agency (KDCA) on Monday published the “2022 Chronic Disease Status and Issues,” which annually provides the basis for establishing the relevant health indus
Inventage Lab, a company specializing in gene therapy, said that it signed a joint development and commercialization contract with Chong Kun Dang Pharmaceutical for a long-lasting persistent dementia injection, IVL3003, on Monday.The pipeline, which gave Chong Kun Dang exclusive rights, is a dementi
The Ministry of Food and Drug Safety (MFDS) said it has granted emergency use approval (EUA) for Pfizer's Covid-19 bivalent vaccine, an improved vaccine developed to respond to the Omicron variants.The Emergency Use Approval System allows the urgent manufacture, import, and supply of medical product
A lawmaker has called for a check to reduce the indiscriminate hormone treatments of precious puberty, pointing out that health insurance claims have sharply increased since the Covid-19 outbreak.Rep. Shin Hyun-young of the opposition Democratic Party of Korea (DPK) said so on Sunday based on her an
Lunit said its artificial intelligence (AI)-based imaging analysis solution Lunit Insight CXR's reading accuracy was similar to that of a radiologist with more than 20 years of experience in a recent study. Lunit conducted the study jointly with the University of Edinburgh's Queen's Medical Research
M2N Bio, an investment partner in Pacylex Pharmaceuticals, said that the PCLX-001 drug to treat patients with acute myeloid leukemia (AML) received U.S. FDA orphan drug designation (ODD) on Saturday.PCLX-001 is the first N-myristoyltransferase (NMT) inhibitor in its class undergoing phase 1 clinical
Both Moderna and Pfizer’s Covid-19 bivalent vaccines have landed in Korea as a booster shot against the Omicron variants.Moderna is expanding the mRNA scope beyond Covid-19 vaccines to tackle other global health issues, said Moderna’s Senior Director of Bacteriology and Infectious Disease Research,
The Korea Electronic Cigarette Association (KECA), a group of about 4,000 e-cigarettes vendors, said it has filed a lawsuit against the Ministry of Health and Welfare (MOHW) and the Korea Disease Control and Prevention Agency (KDCA), demanding the government correct misguided information about e-cig
Yuhan Corp. has set about to secure indications for its non-small cell lung cancer (NSCLC) drug, Leclaza (lazertinib), as the first-line treatment.In a public notice on Friday, Yuhan unveiled part of the topline results of phase 3 clinical trial of Leclazae to win approval as the first-line treatmen
The government is checking quarantine measures for the 2023 College Scholastic Ability Test (CSAT), as the exam is just a month away. The CSAT this year will be the third conducted during the Covid-19 era.A total of 508,030 students will take the CSAT on Nov. 17 nationwide, the Ministry of Education
The market capitalization of Icure Pharmaceutical has shrunk close to 90 billion won ($56 million), which could disrupt its plan to increase 80 billion won in capital.As of 2:40 p.m, Friday, the company’s shares stood at 4,850 won, up 7.3 percent from the previous trading day, with a market cap of 9
“There are over 10,000 rare diseases but how many of them have a cure?” When I introduce the diagnosis of rare diseases, I often get questions about treatment. I tend to give the general answer that therapies are being developed for about 5 percent of rare diseases, and there is no cure for 95 perce
Daewoong Pharmaceutical has released the results of a study on the indication of its P-CAB (potassium-competitive acid blockers)-based drug, Fexuclue (fexuprazan hydrochloride), to treat gastritis at the United European Gastroenterology Week (UEGW) 2022.Daewoong said it unveiled the phase 3 clinical
The Asan Medical Center (AMC), where a nurse’s death occurred in July, should withdraw its Grade 1 rating in the evaluation of the adequacy in treating acute stroke, a lawmaker said.According to the evaluation of adequacy in handling acute stroke made public by the Health Insurance Review and Assess
A multinational research team including Professor Bae Hee-joon of Seoul National University Bundang Hospital (SNUBH) found that ancestry specific stroke genetic risk factors strongly predicted ischemic stroke in European, East Asian and African ancestry.Genome-wide association studies (GWASs) identi
Yongin Severance Hospital said it succeeded in treating a 77-day-old baby suffering from spinal muscular atrophy (SMA) by administering Novartis’ Zolgensma, an ultra-expensive gene therapy covered by the national health insurance program.According to the hospital, it is the nation’s first case of us
The government said 780,000 doses of Pfizer's BA.1-based bivalent vaccine, an improved vaccine developed to respond to the Omicron variant, will arrive in Korea on Thursday.This is the first shipment of Pfizer's bivalent batch to arrive in Korea and comes after the Ministry of Food and Drug Safety g
The Fair Trade Commission (FTC) said AstraZeneca and Alvogen would face a $1.85 million fine together for reaching an unfair deal to prevent the launch of a generic version of AstraZeneca’s Zoladex (ingredient: Gosereline), a drug for breast and prostate cancer, in Korea.The FTC imposed a correction
Foreign residents in Korea paid nearly 1.58 trillion won ($1.11 billion) in health insurance premiums, and the number of foreigners caught illegally receiving insurance money decreased significantly last year.Based on the analysis of data at the National Health Insurance Service, Rep. Koh Young-in o